Literature DB >> 27992158

Medicare and State Health Care Programs: Fraud and Abuse; Revisions to the Safe Harbors Under the Anti-Kickback Statute and Civil Monetary Penalty Rules Regarding Beneficiary Inducements. Final rule.

.   

Abstract

In this final rule, OIG amends the safe harbors to the anti-kickback statute by adding new safe harbors that protect certain payment practices and business arrangements from sanctions under the anti-kickback statute. The OIG also amends the civil monetary penalty (CMP) rules by codifying revisions to the definition of "remuneration," added by the Balanced Budget Act (BBA) of 1997 and the Patient Protection and Affordable Care Act, Public Law 111-148, 124 Stat. 119 (2010), as amended by the Health Care and Education Reconciliation Act of 2010 (ACA). This rule updates the existing safe harbor regulations and enhances flexibility for providers and others to engage in health care business arrangements to improve efficiency and access to quality care while protecting programs and patients from fraud and abuse.

Entities:  

Mesh:

Year:  2016        PMID: 27992158

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  4 in total

1.  Acceptability and Usability of a Reward-Based Mobile App for Opioid Treatment Settings: Mixed Methods Pilot Study.

Authors:  Steven L Proctor; Khary K Rigg; Allen Y Tien
Journal:  JMIR Form Res       Date:  2022-10-05

2.  Rewarding recovery: the time is now for contingency management for opioid use disorder.

Authors:  Steven L Proctor
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  Combating Health Care Fraud and Abuse: Conceptualization and Prototyping Study of a Blockchain Antifraud Framework.

Authors:  Tim Ken Mackey; Ken Miyachi; Danny Fung; Samson Qian; James Short
Journal:  J Med Internet Res       Date:  2020-09-10       Impact factor: 5.428

4.  A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program.

Authors:  Kristen S Lee; Lisa Quintiliani; Alexandra Heinz; Natrina L Johnson; Ziming Xuan; Ve Truong; Karen E Lasser
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.